MFCD19471564
|
- $160 - $700
- Product name: MFCD19471564
- CAS: 1284399-56-9
- MF: C13H8N2O3
- MW: 240.21
- EINECS:
- MDL Number:MFCD19471564
- Synonyms:2-(4-hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione;MFCD19471564;1H-Pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 2-(4-hydroxyphenyl)-
4 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 0.500g
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11300907
- Product description2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number154747
- Product description2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
- Packaging0.500g
- Price$160
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number154747
- Product description2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
- Packaging1g
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number154747
- Product description2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione
- Packaging5g
- Price$700
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11300907 | 2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione 97% | 5g | $527 | 2021-12-16 | Buy |
| Matrix Scientific | 154747 | 2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione | 0.500g | $160 | 2021-12-16 | Buy |
| Matrix Scientific | 154747 | 2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione | 1g | $200 | 2021-12-16 | Buy |
| Matrix Scientific | 154747 | 2-(4-Hydroxyphenyl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione | 5g | $700 | 2021-12-16 | Buy |
Properties
Boiling point :509.1±56.0 °C(Predicted)
Density :1.516±0.06 g/cm3(Predicted)
pka :9.72±0.30(Predicted)
Density :1.516±0.06 g/cm3(Predicted)
pka :9.72±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|